BrainStorm Cell Therapeutics (NASDAQ:BCLI) CMO Dr. Ralph Kern sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.
BrainStorm Cell Therapeutics halfway through enrolling its Phase 3 ALS study
Upcoming Events
6/17 to 6/19
7/8 to 7/10
1/13 to 1/15
1/13 to 1/15
